Register for free to listen to this article
Listen with Speechify
0:00
2:00
We’re going to gaze into our mystical scrying device (it might be a crystal sphere, or perhaps we are simply staring into the dark and steaming depths of our morning coffee) and give you a glimpse of the future. Actually, come to think of it, our scrying device probably looks a lot like the page from the DDNews 2020 media kit with the header “2020 Editorial Planner.”
 
So, if you were expecting any guaranteed winning stock market tips or supernatural knowledge of the next big blockbuster drug target, we are sorry to disappoint. We’re not that good. But we are happy to give you a preview of what’s coming for next year’s special content for the magazine, now that we’re at the end of this year.
 
Certainly, all our content is special (or so we like to think), but as you know if you’re a regular reader (and not a random visitor to an R&D lab picking up a copy of DDNews to keep you busy), in addition to our regular news sections, commentary section and the like, we also feature special features—at least one each month—providing previews of upcoming scientific conferences/annual meetings and coverage of various focused topics (therapeutics or technological approaches usually).
 
On the show preview side in 2020, we will cover ToxExpo, analytica, the American Association for Cancer Research, the American Association of Immunology, the International Society for Stem Cell Research, the Immuno-Oncology Summit, the American Society of Human Genetics, the Society for Neuroscience and the American Society for Cell Biology.
 
For our Focus Features, in which the DDNews editors provide a roundup of recent news in a particular area of interest, we will cover tox screening, CRISPR gene editing and neuroscience, as well as run three cancer research news Focus Features. And maybe one or two surprise Focus Features, too—we’ll see.
 
Finally, for our Special Reports, in which Features Editor Randall C Willis provides an in-depth look at an area of interest, we will see gene therapy, proteomics, neuroscience, cancer, organs-on-a-chip, stem cells, metabolic syndrome and infectious disease covered in 2020—details of the specifics for each to emerge as Randy gets closer to researching and writing them.
 
Whether Christmas, Hanukkah, Solstice, Kwanzaa or maybe something else is your holiday celebration of choice for December, may you have the best of times and come back to us in January refreshed and ready to tackle another year of drug discovery and development.

Related Topics

Published In

Volume 15 - Issue 12 | December 2019

December 2019

December 2019 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A scientist using a digital tablet with futuristic data visualization graphics overlaying the screen, representing advanced laboratory data management and analysis

Unlocking laboratory efficiency: a complete guide to LIMS selection

Discover how to choose, implement, and optimize laboratory information management systems (LIMS) to streamline lab operations and ensure compliance.
Reliable fluid biomarkers strategies for clinical neuroscience research

Reliable fluid biomarkers strategies for clinical neuroscience research

Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
A group of blue capsules is scattered on a bright yellow surface, with one capsule opened to reveal white powder inside.

Understanding drug impurities: types, sources, and analytical strategies

Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue